CTX211
Dead / Abandoned — Abandoned — failure to respond (as of 21 Nov 2024)
What this means for you
This application is over — abandoned 12 Nov 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98347437
- Mark type
- Stylized text
- Filed
- 08 Jan 2024
- Abandoned
- 12 Nov 2024
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
- Class 042 — Scientific and technological services: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
Owner
- CRISPR Therapeutics AG, ZUG V8, CH
Prosecution history
- 21 Nov 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 21 Nov 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 05 Aug 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 05 Aug 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 09 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 May 2024 — NON-FINAL ACTION E-MAILED
- 09 May 2024 — NON-FINAL ACTION WRITTEN
- 01 May 2024 — ASSIGNED TO EXAMINER
- 26 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Jan 2024 — NEW APPLICATION ENTERED